← FDA Drug Approvals (Drugs@FDA)
EPOPROSTENOL SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2024-06-12
Drug application
- FDA Application #
ANDA213913- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EPOPROSTENOL SODIUM
- Generic name
- EPOPROSTENOL
- Active ingredients
- EPOPROSTENOL SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- MYLAN
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2024-06-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown